insect media evaluation for cell growth and … · figure 2: media evaluation -product a...

1
75 Sidney St. Cambridge, MA 02139 USA - [email protected] - 857-259-5340 0 20 40 60 80 100 0 2 4 6 8 10 12 14 16 18 20 -4 -2 0 2 4 6 8 Viability (Dash/Dot Line - %) Viable Cell Density (Solid Line - E6 cells/mL) Average Diameter (Dotted Line - µm) Time (Days Post Infection) Media A Media B Media C Media D Media E Media F Media G 0 20 40 60 80 100 0 2 4 6 8 10 12 14 16 18 20 0 5 10 15 20 Viability (Dash/Dot Line - %) Viable Cell Density (Solid Line - E6 cells/mL) Time (Days) Media A Media B Media C Media D Media E Media F Media G 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 Media C Media F Media G Cell Specific Titer (qPCR - vg/cell) Flask 2L STR 0 5E+10 1E+11 1.5E+11 2E+11 2.5E+11 3E+11 Media C Media F Media G Volumetric Titer (qPCR - vg/mL) Flask 2L STR 0.0E+00 2.0E+11 4.0E+11 6.0E+11 8.0E+11 1.0E+12 1.2E+12 1.4E+12 Media A Media B Media C Media D Media E Media F Media G Volumetric Titer (qPCR - vg/mL) ~25 Gen. ~50 Gen ~75 Gen ~100 Gen 0.0E+00 5.0E+04 1.0E+05 1.5E+05 2.0E+05 2.5E+05 Media A Media B Media C Media D Media E Media F Media G Cell Specific Titer (qPCR - vg/cell) ~25 Gen. ~50 Gen ~75 Gen ~100 Gen 0 20 40 60 80 100 0 2 4 6 8 10 12 14 16 18 20 22 -4 -2 0 2 4 6 8 10 Viability (Dash/Dot Line - %) Viable Cell Density (Solid Line - E6 cells/mL) Average Diameter (Dotted Line - µm) Time (Days Post Infection) Media C (Flask) Media F (Flask) Media G (Flask) Media C (2L STR, N=2) Media D (2L STR, N=2) Media G (2L STR, N=3) INSECT MEDIA EVALUATION FOR CELL GROWTH AND rAAV PRODUCTION IN AN SF9-BACULOVIRUS SYSTEM Taylor Polhemus 1 , Hui Wu 1 , David Dismuke 2 , and Christopher J. Morrison 1 ABSTRACT Expanding clinical efforts utilizing rAAV vectors have required continuous improvements in rAAV manufacturing. Particularly, increased product supply demands have fueled efforts to maximize volumetric productivity of the cell culture process. One avenue to improve volumetric productivity is the optimization of cell culture media. In this work we compare the performance of a range of commercially available Sf9-specific cell culture media. Cells were maintained for approximately 100 population doublings to evaluate media robustness and ensure full adaptation to the assorted media. Multiple rounds of vector production were performed using various AAV serotypes to investigate the impact of the different media on the quantity and quality of vector produced. Furthermore, terminal batch growth cultures were conducted to investigate differences in growth and metabolic profiles. The importance of media selection and optimization in platform development is demonstrated in this work by marked volumetric and cellular productivity improvement for our process. These results highlight the significant impact that the cell culture media has on the production of rAAV in the Sf9-Baculovirus manufacturing system. 1 Voyager Therapeutics, 75 Sidney St, Cambridge, MA 02139 Figure 1: Maintenance and Terminal Growth Curve Comparison Overview A A) Flask maintenance data. Generations are defined as a population doubling in culture. Certain conditions were terminated before the four production rounds were completed due to poor growth or productivity. Media B, C, F and G were maintained for the full duration of the experiment. B) Subset of the terminal batch growth data for the different media evaluated. All conditions were seeded at 1.0E6 viable cells/mL in shake flasks. No further supplementation was provided over the course of the batch. Cell growth parameters were generated by offline sampling using the Nexelcom Cellometer Auto T4 (Cellometer). Media ID Serum-Free Animal Origin Free Hydrolysate/ Yeastolates A × B C D E × F G Host Cell Line Spodoptera frugiperda 9 (Sf9 – Insect) Baculovirus Expression vector to produce recombinant Adeno-Associated Virus Product A = RH10 Capsid Product B = AAV2 Capsid Production of rAAV in the Sf9/Baculovirus System Evaluation: Media was evaluated over the course of 5 months for a defined set of criteria Passaging Terminal Batch Media ID Total Gen. Avg. Doubling Time (hrs.) CV% Avg. Peak VCD (E6 cells/mL) Length to 70% Viability (days) A 45.7 29.3 7.2 8.7 10 B 114 36.8 13.3 16.3 10 C 138.3 28.7 5.4 16.5 13 D 39.6 58.0 38.6 8.4 10 E 71.9 39.1 8.0 10.7 10 F 96.4 36.6 4.1 16.8 10 G 127.3 28.9 4.9 13.0 8 Figure 2: Media Evaluation - Product A Differences in cell growth were observed and were not directly correlated to the differences in the terminal batch growth evaluation. Media F was the highest producing media tested with an average qPCR titer of 1.06E12 vg/mL. With the exception of Media E, cell line age (Generation) could not be correlated to productivity. Rank order was highly conserved whether comparing productivity by volumetric or cell specific productivity. Volumetric Productivity (F > E > G > B > D > C> A) vs. Cell Specific Productivity (F > E > G > B > C > D > A) A) Cell parameter data for the production of Product A. All conditions are representative of the platform process used to produce Product A. The production flasks were operated at a working volume of 200 mL in a 500mL shake flask. Cultures were infected with baculovirus on Day 0 of culture. Cell growth parameters were generated by offline sampling using the Nexelcom Cellometer Auto T4 (Cellometer). B) Volumetric Titer’s are quantified by qPCR on clarified lysate samples. C) Cell specific productivity is defined as: !"#$%&%'( )*+#,' -%,'$ ( /0 12 ) 4'#5 6%#7"' !'"" 8'9+%,* (:; <=>>? 12 ) A B C Figure 3: Media Evaluation - Product B CONCLUSIONS The data presented highlight the range of performance in commercially available Sf9 cell culture media. Screening commercially available cell culture media was shown to produce a full log of dynamic range in volumetric and cell specific productivity for two different therapeutics. Rank order of commercially available cell culture media was conserved across products and scale down models (Flask vs. 2L STR). The authors would like to acknowledge and thank the following parties for their contribution(s) to the data presented:Process Analytics/Analytical Development Group at Voyager; Process Development Group at Voyager ACKNOWLEDGMENTS A range of peak viable cell densities was observed across the media tested. Peak viable cell density ranged from 6-10E6 viable cells/mL. Media C and G experienced an accelerated decline in viability compared to Media B and F. Media F consistently exhibits an inflated average cell diameter across the duration of culture compared to the other media tested. Ranking of media productivity by both volumetric and cell specific productivity was not impacted by the product used. Rank order was conserved across the two products tested (Media F > G > B > C). A) Cell parameter data for the production of Product B. All conditions are representative of the platform process used to produce Product B. The production flasks were operated at a working volume of 200 mL in a 500mL shake flask. Cultures were infected with baculovirus on Day 0 of culture. Cell growth parameters were generated by offline sampling using the Nexelcom Cellometer Auto T4 (Cellometer) . B) Volumetric Titer’s are quantified by qPCR on clarified lysate samples. Cell specific productivity is defined as: !"#$%&%'( )*+#,' -%,'$ ( /0 12 ) 4'#5 6%#7"' !'"" 8'9+%,* (:; <=>>? 12 ) A B Figure 4: Impact of Scale on Media Evaluation Cell growth parameters trend consistently between flask and 2L STR for Media C and G. A delay in infection kinetics was observed for Media F when comparing the flask trend to the 2L STR. Peak viable cell density, viability decline, and timing of average diameter increase are delayed ~ 24 hours respectively. Media F was again the highest producing media on a volumetric and cell specific basis. Ranking of media by volumetric and cell specific productivity was not impacted by the scale used for evaluation. Rank order was conserved from the shake flask evaluation (Media F > G > C). A) Cell parameter data for the production of Product B at the Flask (200mL Working Volume in 500 mL Flask), and 2L STR scales. All conditions are representative of the platform process used to produce Product B. The 2L STR trends are averaged values with the number of replicates specified in the legend. Cultures were infected with baculovirus on Day 0 of culture. Cell growth parameters were generated by offline sampling using the Nexelcom Cellometer Auto T4 (Cellometer). B) Volumetric Titer’s are quantified by qPCR on clarified lysate samples. C) Cell specific productivity is defined as: !"#$%&%'( )*+#,' -%,'$ ( /0 12 ) 4'#5 6%#7"' !'"" 8'9+%,* (:; <=>>? 12 ) A B C Volumetric Titer Cell Specific Titer Cell Parameters Titer Combined Cell Parameters Volumetric Titer Cell Specific Titer Cell Parameters Purified rAAV Various Purification Operations Infection with baculovirus Production occurs in various vessels Sf9 cells cultured in suspension Purification of harvest The average doubling times of Sf9 cells in Media A, C, and G fell within the average literature range of 24-30 hours. The average doubling times of Sf9 cells in Media B, D, E and F exceeded the average literature range. Media F and G exhibited the most consistent doubling times with a CV of less than 5% over the maintenance timeframe. Media C displayed the most robust performance in the terminal batch growth evaluation. The media was able to support a high maximum viable cell density (avg. 16.5E6 viable cells/mL) while maintaining high viability (> 80%) through Day 13 in terminal batch growth. Adaptation and Stability Cells were passaged in respective media for ~100 generations Terminal Batch Growth Compare peak densities in batch growth Production Comparison Four rounds of rAAV Production- Compare productivity and quality attributes B Media Summary Passaging Summary Cell Parameters 0 20 40 60 80 100 0 2 4 6 8 10 12 14 16 18 20 22 -4 -2 0 2 4 6 8 Viability (Dash/Dot Line - %) Viable Cell Density (Solid Line - E6 cells/mL) Average Diameter (Dotted Line - µm) Time (Days Post Infection) Media B Media C Media F Media G 1 10 100 1000 10000 100000 0 5E+10 1E+11 1.5E+11 2E+11 2.5E+11 3E+11 3.5E+11 4E+11 4.5E+11 5E+11 Media B Media C Media F Media G Cell Specific Titer (Line - qPCR - vg/cell) Volumetric Titer (Bar - qPCR - vg/mL) Volumetric Titer Cell Specific Titer Experimental Range = ~1E11 - 1E12 vg/mL Experimental Range = ~1E4 - 2E5 vg/cell NOTES: 2 Formerly of Voyager Therapeutics, currently at StrideBio, Durham, NC Abstract #640 ASGCT 2018

Upload: others

Post on 22-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: INSECT MEDIA EVALUATION FOR CELL GROWTH AND … · Figure 2: Media Evaluation -Product A •Differences in cell growth were observed and were not directly correlated to the differences

75 Sidney St. Cambridge, MA 02139 USA - [email protected] - 857-259-5340

-140

-120

-100

-80

-60

-40

-20

0

20

40

60

80

100

0

2

4

6

8

10

12

14

16

18

20

22

24

26

28

30

-4 -2 0 2 4 6 8

Via

bilit

y (D

ash/

Dot

Lin

e -

%)

Via

ble

Cel

l Den

sity

(Sol

id L

ine

-E6

cel

ls/m

L)Ave

rage

Dia

met

er (

Dot

ted

Line

-µm

)

Time (Days Post Infection)

Media A Media B Media C Media DMedia E Media F Media G

-100

-80

-60

-40

-20

0

20

40

60

80

100

0

2

4

6

8

10

12

14

16

18

20

22

24

26

28

30

0 5 10 15 20

Via

bilit

y (D

ash/

Dot

Lin

e -

%)

Via

ble

Cel

l Den

sity

(Sol

id L

ine

-E6

cel

ls/m

L)

Time (Days)

Media A Media B Media C Media D Media E Media F Media G

0

5000

10000

15000

20000

25000

30000

35000

40000

45000

Media C Media F Media G

Cel

l Spe

cific

Tite

r (q

PCR -

vg/c

ell)

Flask 2L STR

0

5E+10

1E+11

1.5E+11

2E+11

2.5E+11

3E+11

Media C Media F Media G

Vol

umet

ric

Tite

r (q

PCR -

vg/m

L)

Flask 2L STR

0.0E+00

2.0E+11

4.0E+11

6.0E+11

8.0E+11

1.0E+12

1.2E+12

1.4E+12

Media A Media B Media C Media D Media E Media F Media GVol

umet

ric

Tite

r (q

PCR -

vg/m

L)

~25 Gen. ~50 Gen ~75 Gen ~100 Gen

0.0E+00

5.0E+04

1.0E+05

1.5E+05

2.0E+05

2.5E+05

Media A Media B Media C Media D Media E Media F Media G

Cel

l Spe

cific

Tite

r (q

PCR -

vg/c

ell)

~25 Gen. ~50 Gen ~75 Gen ~100 Gen

-140

-120

-100

-80

-60

-40

-20

0

20

40

60

80

100

02468

10121416182022242628303234

-4 -2 0 2 4 6 8 10

Via

bilit

y (D

ash/

Dot

Lin

e -

%)

Via

ble

Cel

l Den

sity

(Sol

id L

ine

-E6

cel

ls/m

L)Ave

rage

Dia

met

er (

Dot

ted

Line

-µm

)

Time (Days Post Infection)Media C (Flask) Media F (Flask)

Media G (Flask) Media C (2L STR, N=2)

Media D (2L STR, N=2) Media G (2L STR, N=3)

INSECT MEDIA EVALUATION FOR CELL GROWTH AND rAAV PRODUCTION IN AN SF9-BACULOVIRUS SYSTEMTaylor Polhemus1, Hui Wu1, David Dismuke2, and Christopher J. Morrison1

ABSTRACTExpanding clinical efforts utilizing rAAV vectors have required continuousimprovements in rAAV manufacturing. Particularly, increased productsupply demands have fueled efforts to maximize volumetric productivity ofthe cell culture process. One avenue to improve volumetric productivity isthe optimization of cell culture media. In this work we compare theperformance of a range of commercially available Sf9-specific cell culturemedia. Cells were maintained for approximately 100 population doublingsto evaluate media robustness and ensure full adaptation to the assortedmedia. Multiple rounds of vector production were performed using variousAAV serotypes to investigate the impact of the different media on thequantity and quality of vector produced. Furthermore, terminal batchgrowth cultures were conducted to investigate differences in growth andmetabolic profiles. The importance of media selection and optimization inplatform development is demonstrated in this work by marked volumetricand cellular productivity improvement for our process. These resultshighlight the significant impact that the cell culture media has on theproduction of rAAV in the Sf9-Baculovirus manufacturing system.

1Voyager Therapeutics, 75 Sidney St, Cambridge, MA 02139

Figure 1: Maintenance and Terminal Growth Curve Comparison

Overview

A

A) Flask maintenance data. Generations aredefined as a population doubling in culture.Certain conditions were terminated beforethe four production rounds were completeddue to poor growth or productivity. Media B,C, F and G were maintained for the fullduration of the experiment.

B) Subset of the terminal batch growth datafor the different media evaluated. Allconditions were seeded at 1.0E6 viablecells/mL in shake flasks. No furthersupplementation was provided over thecourse of the batch. Cell growth parameterswere generated by offline sampling usingthe Nexelcom Cellometer Auto T4(Cellometer).

Media ID Serum-Free Animal Origin Free Hydrolysate/

Yeastolates

A ✓ × ✓B ✓ ✓ ✓C ✓ ✓ ✓D ✓ ✓ ✓E ✓ × ✓F ✓ ✓ ✓G ✓ ✓ ✓

• Host Cell Line – Spodoptera frugiperda 9 (Sf9 – Insect)• Baculovirus – Expression vector to produce recombinant Adeno-Associated Virus• Product A = RH10 Capsid• Product B = AAV2 Capsid

Production of rAAV in the Sf9/Baculovirus System

Evaluation: Media was evaluated over the course of 5 months for a defined set of criteria

Passaging Terminal Batch

Media ID

Total Gen.

Avg. Doubling Time (hrs.)

CV% Avg. Peak VCD(E6 cells/mL)

Length to 70% Viability

(days)

A 45.7 29.3 7.2 8.7 10

B 114 36.8 13.3 16.3 10

C 138.3 28.7 5.4 16.5 13

D 39.6 58.0 38.6 8.4 10

E 71.9 39.1 8.0 10.7 10

F 96.4 36.6 4.1 16.8 10

G 127.3 28.9 4.9 13.0 8

Figure 2: Media Evaluation - Product A • Differences in cell growth were observed

and were not directly correlated to the differences in the terminal batch growth evaluation.

• Media F was the highest producing media tested with an average qPCR titer of 1.06E12 vg/mL.

• With the exception of Media E, cell line age (Generation) could not be correlated to productivity.

• Rank order was highly conserved whether comparing productivity by volumetric or cell specific productivity.

• Volumetric Productivity –(F > E > G > B > D > C> A) vs. Cell Specific Productivity –(F > E > G > B > C > D > A)

A) Cell parameter data for the production of Product A. All conditions are representative of the platform process used toproduce Product A. The production flasks were operated at a working volume of 200 mL in a 500mL shake flask. Cultureswere infected with baculovirus on Day 0 of culture. Cell growth parameters were generated by offline sampling using theNexelcom Cellometer Auto T4 (Cellometer).

B) Volumetric Titer’s are quantified by qPCR on clarified lysate samples.

C) Cell specific productivity is defined as:!"#$%&%'( )*+#,' -%,'$ (/012)

4'#5 6%#7"' !'"" 8'9+%,* (:;<=>>?12 )

A

B C

Figure 3: Media Evaluation - Product B

CONCLUSIONS• The data presented highlight the range of performance in commercially

available Sf9 cell culture media.

• Screening commercially available cell culture media was shown toproduce a full log of dynamic range in volumetric and cell specificproductivity for two different therapeutics.

• Rank order of commercially available cell culture media was conservedacross products and scale down models (Flask vs. 2L STR).

The authors would like to acknowledge and thank the following parties for their contribution(s) to the data presented:Process Analytics/Analytical Development Group at Voyager; Process Development Group at Voyager

ACKNOWLEDGMENTS

• A range of peak viable cell densities was observed across the media tested. Peak viable cell density ranged from 6-10E6 viable cells/mL.

• Media C and G experienced an accelerated decline in viability compared to Media B and F.

• Media F consistently exhibits an inflated average cell diameter across the duration of culture compared to the other media tested.

• Ranking of media productivity by both volumetric and cell specific productivity was not impacted by the product used. Rank order was conserved across the two products tested (Media F > G > B > C).

A) Cell parameter data for the production of Product B. All conditions are representative of the platform process used toproduce Product B. The production flasks were operated at a working volume of 200 mL in a 500mL shake flask. Cultureswere infected with baculovirus on Day 0 of culture. Cell growth parameters were generated by offline sampling using theNexelcom Cellometer Auto T4 (Cellometer) .

B) Volumetric Titer’s are quantified by qPCR on clarified lysate samples.

Cell specific productivity is defined as:!"#$%&%'( )*+#,' -%,'$ (/012)

4'#5 6%#7"' !'"" 8'9+%,* (:;<=>>?12 )

A B

Figure 4: Impact of Scale on Media Evaluation

• Cell growth parameters trend consistently between flask and 2L STR for Media C and G.

• A delay in infection kinetics was observed for Media F when comparing the flask trend to the 2L STR. Peak viable cell density, viability decline, and timing of average diameter increase are delayed ~ 24 hours respectively.

• Media F was again the highest producing media on a volumetric and cell specific basis.

• Ranking of media by volumetric and cell specific productivity was not impacted by the scale used for evaluation. Rank order was conserved from the shake flask evaluation (Media F > G > C).

A) Cell parameter data for the production of Product B at the Flask (200mL Working Volume in 500 mL Flask), and 2L STRscales. All conditions are representative of the platform process used to produce Product B. The 2L STR trends areaveraged values with the number of replicates specified in the legend. Cultures were infected with baculovirus on Day 0 ofculture. Cell growth parameters were generated by offline sampling using the Nexelcom Cellometer Auto T4 (Cellometer).

B) Volumetric Titer’s are quantified by qPCR on clarified lysate samples.

C) Cell specific productivity is defined as:!"#$%&%'( )*+#,' -%,'$ (/012)

4'#5 6%#7"' !'"" 8'9+%,* (:;<=>>?12 )

A

B C

Volumetric Titer Cell Specific Titer

Cell Parameters

Titer CombinedCell Parameters

Volumetric Titer Cell Specific Titer

Cell Parameters

Purified rAAV

Various Purification Operations

Infection with baculovirus

Production occurs in various vessels

Sf9 cells cultured in suspension

Purification of harvest

• The average doubling times of Sf9 cells in Media A, C, and G fell within the average literature range of 24-30 hours. The average doubling times of Sf9 cells in Media B, D, E and F exceeded the average literature range.

• Media F and G exhibited the most consistent doubling times with a CV of less than 5% over the maintenance timeframe.

• Media C displayed the most robust performance in the terminal batch growth evaluation. The media was able to support a high maximum viable cell density (avg. 16.5E6 viable cells/mL) while maintaining high viability (> 80%) through Day 13 in terminal batch growth.

• Adaptation and StabilityCells were passaged in respective media for ~100 generations• Terminal Batch Growth

Compare peak densities in batch growth• Production Comparison

Four rounds of rAAV Production- Compare productivity and quality attributes

B

Media Summary

Passaging Summary

Cell Parameters

-140

-120

-100

-80

-60

-40

-20

0

20

40

60

80

100

02468

10121416182022242628303234

-4 -2 0 2 4 6 8

Via

bilit

y (D

ash/

Dot

Lin

e -

%)

Via

ble

Cel

l Den

sity

(Sol

id L

ine

-E6

cel

ls/m

L)Ave

rage

Dia

met

er (

Dot

ted

Line

-µm

)

Time (Days Post Infection)

Media B Media C Media F Media G

1

10

100

1000

10000

100000

0

5E+10

1E+11

1.5E+11

2E+11

2.5E+11

3E+11

3.5E+11

4E+11

4.5E+11

5E+11

Media B Media C Media F Media G

Cel

l Spe

cific

Tite

r (L

ine

-qP

CR -

vg/c

ell)

Vol

umet

ric

Tite

r (B

ar -

qPC

R -

vg/m

L)

Volumetric Titer Cell Specific Titer

Experimental Range = ~1E11 - 1E12 vg/mL

Experimental Range = ~1E4 - 2E5 vg/cell

NOTES: 2Formerly of Voyager Therapeutics, currently at StrideBio, Durham, NC

Abstract #640ASGCT 2018